RBC raises target for Siemens Healthineers stock to EUR 48.00

Published on 10/26/2026 at 17:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q4 results are due November 5, 2026. Siemens Healthineers stock costs EUR 42.16 on October 26, 2026, up 0.72 percent versus the Xetra close.

RBC target and reporting date

RBC raised its Siemens Healthineers target from EUR 45.00 to EUR 48.00 on October 16, 2026.
Siemens Healthineers scheduled fourth-quarter results and an analyst call for November 5, 2026.
Siemens Healthineers stock costs EUR 42.16 at Lang & Schwarz on October 26, 2026 at 5:04 p.m. CET, 0.72 percent above the Xetra close of October 23, 2026, and 15.17 percent below its 52-week high.
Third-quarter revenue reached EUR 5.764 billion, with 2.80 percent comparable growth in the reported period.

Siemens Healthineers, DE000SHL1006, Illustration mit AI erstellt.

RBC raised its Siemens Healthineers target from EUR 45.00 to EUR 48.00 and kept its Outperform rating on October 16, 2026, according to MarketScreener. The target is 13.85 percent above the EUR 42.16 Lang & Schwarz price. Siemens Healthineers was trading at EUR 42.16 at Lang & Schwarz on October 26, 2026 at 5:04 p.m. CET, 0.72 percent above the Xetra close of October 23, 2026 at EUR 41.86.

November 5 brings the next report

Siemens Healthineers lists fourth-quarter results and its analyst call for November 5, 2026, followed by a US roadshow on November 6, 2026, on its investor-relations page. The scheduled report gives the RBC target a near-term test, because the latest quarterly figures combined operating progress with a softer growth outlook.

Stock stays below its yearly high

The stock's 52-week range was EUR 32.81 to EUR 49.70 as of October 26, 2026. At EUR 42.16, it stood 15.17 percent below the high and 28.50 percent above the low. The year-to-date performance was minus 6.81 percent at the October 23, 2026 Xetra close, while reported volume for October 26, 2026 was 659,146 shares.

Siemens Healthineers also disclosed a share buyback interim report on October 19, 2026. According to MarketScreener, the company bought back 55,000 shares between October 12 and October 18, 2026, bringing the cumulative program total to 3,529,346 shares.

Quarterly figures set the baseline

For the third quarter of fiscal 2026, revenue reached EUR 5.764 billion, comparable revenue growth was 2.80 percent, and adjusted operating margin was 19.10 percent. Adjusted earnings per share reached EUR 0.70, while free cash flow was EUR 1.023 billion, according to Admiral Markets. The margin and earnings figures included the effect of tariff refunds, which makes the next report important for assessing underlying operating performance.

Valuation leaves room for debate

Siemens Healthineers had a price-to-earnings ratio of 21.31 and a market capitalization of EUR 47.2 billion as of October 26, 2026. RBC's EUR 48.00 target is 13.85 percent above the Lang & Schwarz price, while the latest reported earnings and the November 5 date provide the next measurable checkpoints.

What the EUR 48 target means

RBC's target places the emphasis on execution rather than on a broad market move. The combination of 2.80 percent comparable revenue growth in the third quarter and a 19.10 percent adjusted operating margin gives investors two concrete measures for judging the outlook.

The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.